Cost-Effectiveness of Oxaliplatin in the Adjuvant Treatment of Colon Cancer in Canada
Abstract
Share and Cite
Attard, C.L.; Maroun, J.A.; Alloul, K.; Grima, D.T.; Bernard, L.M. Cost-Effectiveness of Oxaliplatin in the Adjuvant Treatment of Colon Cancer in Canada. Curr. Oncol. 2010, 17, 17-24. https://doi.org/10.3747/co.v17i1.436
Attard CL, Maroun JA, Alloul K, Grima DT, Bernard LM. Cost-Effectiveness of Oxaliplatin in the Adjuvant Treatment of Colon Cancer in Canada. Current Oncology. 2010; 17(1):17-24. https://doi.org/10.3747/co.v17i1.436
Chicago/Turabian StyleAttard, C. L., J. A. Maroun, K. Alloul, D. T. Grima, and L. M. Bernard. 2010. "Cost-Effectiveness of Oxaliplatin in the Adjuvant Treatment of Colon Cancer in Canada" Current Oncology 17, no. 1: 17-24. https://doi.org/10.3747/co.v17i1.436
APA StyleAttard, C. L., Maroun, J. A., Alloul, K., Grima, D. T., & Bernard, L. M. (2010). Cost-Effectiveness of Oxaliplatin in the Adjuvant Treatment of Colon Cancer in Canada. Current Oncology, 17(1), 17-24. https://doi.org/10.3747/co.v17i1.436